Wholesaler News
ANNOUNCEMENT – Aspen Pharmacare – Discontinuation – Fentanyl 2mL and Fentanyl 10mL
Aspen Pharmacare Australia Pty Ltd wish to advise you that we have discontinued the supply of Fentanyl 2mg x 5amps and Fentanyl 10ml. Download Letter – Fentanyl 2mL Download Letter – Fentanyl 10mL
Read MoreANNOUNCEMENT – Aspen Pharmacare – Discontinuation of Fera 2.5mg x 30 tabs
Aspen Pharmacare Australia Pty Ltd wish to advise you that we have discontinued the supply of Fera 2.5mg Tab x 30, effective immediately. Please keep selling the stock on hand you have. There is no further stock available from our warehouse. Any backorders Aspen are holding will be deleted. Download Letter Please wait a moment…
Read MoreANNOUNCEMENT – Aspen Pharmacare – Price Increase QUILONUM SR 450MG TABS X 100
Aspen Pharmacare Australia Pty Ltd wishes to advise that there will be a price increase for QUILONUM SR 450MG TABS X 100 on 1st of June 2022. Download Letter Please wait a moment for the document to load.
Read MoreANNOUNCEMENT – Aspen Pharmacare – Transfer of Novalac infant formula range from Bayer Australia Limited (Bayer) to Aspen Pharmacare Australia Pty Ltd (Aspen)
Aspen and Bayer wish to advise you that distribution of the Novalac range of infant formula will be transferred from Bayer to Aspen effective from 1st June 2022. Please transfer existing pricing and deal structures with the product. Download Letter Please wait a moment for the document to load.
Read MoreANNOUNCEMENT – Aspen Pharmacare – New Product – MwA 0.5% 20 mL vials
Aspen is pleased to announce the launch of new SKU, Marcain 0.5% with Adrenaline. The details are listed in the table below. Download Letter Download NPSA Form Please wait a moment for the document to load.
Read MoreANNOUNCEMENT – Aspen Pharmacare – Transfer of products from Aspen Pharmacare Australia Pty Ltd (Aspen) to ORION PHARMA (AUS) PTY LIMITED (Orion)
Aspen and Orion wish to advise you that distribution of the Orion range of products will be transferred from Aspen to Orion effective from 16th May 2022. Please transfer existing pricing and deal structures with the product. Download Letter Please wait a moment for the document to load.
Read MoreANNOUNCEMENT – Aspen Pharmacare – Product Code Change – Dymandon 2-12 yrs Orange 200mL
Aspen Pharmacare Australia Pty Ltd wishes to advise you on a change of Product Code of Dymadon 2-12yrs Orange 200mL. The EAN number remains the same. Please update your records. Download Letter Download NPSA Form Please wait a moment for the document to load.
Read MoreANNOUNCEMENT – Aspen Pharmacare – New Product – MwA 0.25% 20 mL vials
Aspen is pleased to announce the launch of new SKU, Marcain 0.25% with Adrenaline.The details are listed in the table below. Download Letter Download NPSA Form Please wait a moment for the document to load.
Read MoreANNOUNCEMENT – Aspen Pharmacare – Notification of some MARCAIN with ADRENALINE & XYLOCAINE with ADRENALINE Product Shortage
Following on from the notification Aspen sent (dated 9 March 2022), AstraZeneca (AZ) the contracted manufacturer of Aspen’s local anaesthetic agents, has advised the below SKUs will be on backorder until the anticipated delivery dates as listed. We will continue to provide regular stock updates. Download Letter Please wait a moment for the document to…
Read MoreANNOUNCEMENT – Aspen Pharmacare – New product – Xylocaine ADR N_AC 2% and Xylocaine ADR N_AC 1%
Aspen is pleased to announce the launch of 2 new SKUs of Xylocaine with Adrenaline. Download Letter Download NPSA Form – XYLOCAINE ADR 10MG/ML SDV 5x20ML N-AC Download NPSA Form – XYLOCAINE ADR 20MG/ML SDV 5x20ML N-AC Please wait a moment for the document to load.
Read More